RM

Rajiv Malhotra

Active Director Director DIN 01435601
DIN 01435601 First appointment Jun 1992 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 1992
Shareholding value •••• Premium profile

About Rajiv Malhotra

Data last updated:

Rajiv Malhotra is a Director at Srdass Pharmaceuticals Pvt Ltd (since 1992). The company operates in Chemicals. Srdass Pharmaceuticals Pvt Ltd reported revenue of ₹18 Lakh (FY 2024).

DIN 01435601
Primary Designation Director
Industry Chemicals
First Appointment 24 Jun 1992
Oldest Company Age 34 yrs
Largest company Srdass Pharmaceuticals Pvt Ltd · ₹18 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Srdass Pharmaceuticals Pvt Ltd U24232PB1992PTC012410
Director24 Jun 19921992₹18 Lakh (FY 2024)Active

Board colleagues of Rajiv Malhotra

NameDINCompanyDesignation
Anshu09127714Srdass Pharmaceuticals Pvt LtdDirector

Directorship timeline

Open interactive timeline →
Srdass Pharmaceuticals Pvt Ltd
Premium access

Shareholding and investment profile for Rajiv Malhotra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajiv Malhotra

Rajiv Malhotra currently holds 1 directorship: Srdass Pharmaceuticals Pvt Ltd (Director, since 24 Jun 1992, revenue ₹18 Lakh (FY 2024)).

Rajiv Malhotra was first appointed on 24 Jun 1992 as Director at Srdass Pharmaceuticals Pvt Ltd.

The current boards of Rajiv Malhotra's companies include Anshu (Srdass Pharmaceuticals Pvt Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available